TrialThe British journal of ophthalmology2015

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study.

Robert N Weinreb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.